GSK Income Statement (2009-2025) | GSK

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Mar2009	Jun2009	Sep2009	Dec2009	Mar2010	Jun2010	Sep2010	Dec2010	Mar2011	Jun2011	Sep2011	Dec2011	Mar2012	Jun2012	Sep2012	Dec2012	Mar2013	Jun2013	Sep2013	Dec2013	Mar2014	Jun2014	Sep2014	Dec2014	Mar2015	Jun2015	Sep2015	Dec2015	Mar2016	Jun2016	Sep2016	Dec2016	Mar2017	Jun2017	Sep2017	Dec2017	Mar2018	Jun2018	Sep2018	Dec2018	Mar2019	Jun2019	Sep2019	Dec2019	Mar2020	Jun2020	Sep2020	Dec2020	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025
Revenue & cost
Revenue	9.73B	10.45B	11.09B	13.22B	11.48B	10.49B	10.56B	11.37B	10.55B	10.96B	11.44B	10.97B	10.43B	10.23B	10.31B	10.92B	10.06B	10.16B	10.09B	11.18B	9.29B	9.36B	9.44B	36.45B	8.53B	9.01B	9.50B	36.30B	8.93B	9.38B	9.91B	8.12B	9.15B	9.35B	10.26B	9.44B	10.05B	9.96B	10.55B	10.55B	9.97B	10.04B	11.57B	11.44B	11.65B	9.47B	11.16B	45.03B	7.11B	8.16B	9.14B	9.54B	9.65B	8.73B	9.23B	16.56B	8.45B	8.98B	10.32B	17.54B	9.34B	9.95B	10.41B	19.57B	9.47B	10.65B	11.53B
Cost of Revenue	2.57B	2.62B	2.92B	3.46B	3.05B	2.47B	2.96B	3.28B	3.00B	2.84B	3.35B	12.02B	2.84B	3.15B	3.29B	3.24B	3.07B	3.03B	3.27B	13.90B	2.88B	2.90B	3.06B	11.60B	3.19B	3.07B	3.42B	11.41B	3.06B	3.05B	3.32B	3.12B	3.11B	3.35B	3.47B	13.73B	3.33B	3.15B	3.44B	3.74B	3.56B	3.39B	4.00B	4.18B	4.10B	3.04B	3.72B	4.19B	2.28B	2.39B	2.78B	3.75B	3.65B	2.74B	2.86B	11.21B	2.36B	2.42B	2.88B	10.63B	2.50B	2.68B	3.11B	11.61B	2.44B	2.89B	3.05B
Gross Profit	7.36B	7.94B	8.25B	9.79B	8.48B	8.06B	7.66B	8.24B	7.55B	8.11B	8.09B	31.02B	7.59B	7.08B	7.02B	7.68B	6.99B	7.14B	6.82B	29.01B	6.40B	6.46B	6.38B	6.59B	5.34B	5.94B	6.08B	5.68B	5.87B	6.33B	6.60B	6.31B	6.03B	6.01B	6.79B	6.75B	6.72B	6.81B	7.11B	6.81B	6.42B	6.65B	7.57B	7.27B	7.55B	6.43B	7.43B	29.57B	4.83B	5.77B	6.36B	5.78B	6.00B	5.99B	6.37B	10.82B	6.09B	6.56B	7.44B	12.73B	6.84B	7.27B	7.30B	14.32B	7.03B	7.77B	8.48B
Operating items
Research & Development	-1.62B	-1.51B	-1.45B	-1.84B	-1.81B	-1.79B	-1.56B	-1.73B	-1.47B	-1.65B	-1.58B	-1.72B	-1.53B	-1.46B	-1.47B	-1.84B	-1.41B	-1.61B	-1.39B	-6.35B	-1.42B	-1.36B	-1.34B	-5.47B	-1.31B	-1.24B	-1.28B	-4.70B	-1.17B	-1.28B	-1.21B	-1.25B	-1.19B	-1.61B	-1.37B	-1.61B	-1.26B	-1.26B	-1.29B	-1.38B	-1.31B	-1.43B	-1.49B	-1.60B	-1.52B	-1.62B	-1.47B	-1.94B	-1.46B	-1.63B	-1.95B	-1.85B	-1.48B	-1.56B	-1.59B	-6.44B	-1.53B	-1.68B	-2.00B	-7.72B	-1.82B	-1.86B	-1.90B	-8.22B	-1.84B	-2.70B	-2.28B
Share-based Compensation (IS)												0.07B				-0.04B				0.07B				-0.09B
Selling, General & Administrative	-3.16B	-3.55B	-3.52B	-4.83B	-3.67B	-6.27B	-3.16B	-7.05B	-3.33B	-3.66B	-3.24B	-13.37B	-3.35B	-3.46B	-3.51B	-14.11B	-3.23B	-3.40B	-3.08B	-3.56B	-3.26B	-3.46B	-3.36B	-3.50B	-3.37B	-3.89B	-3.05B	-12.11B	-3.14B	-3.12B	-3.01B	-3.37B	-3.04B	-3.04B	-3.02B	-12.84B	-3.21B	-3.35B	-3.29B	-3.37B	-3.22B	-3.33B	-3.57B	-14.66B	-3.74B	-3.36B	-3.44B	-15.13B	-2.08B	-2.36B	-2.31B	-2.96B	-2.43B	-2.60B	-2.42B	-9.82B	-2.60B	-2.84B	-2.91B	-11.65B	-2.65B	-3.11B	-4.94B	-14.14B	-2.61B	-2.85B	-3.02B
Restructuring Costs												0.15B	-0.13B	-0.09B	-0.28B	0.00B	-0.23B	-0.27B	-0.20B	-0.84B	-0.13B	-0.17B	-0.19B	1.19B	1.31B	0.49B	0.55B	3.40B	0.66B	2.58B	1.05B	-0.30B	0.11B	1.57B	0.05B	-0.21B												1.73B	0.09B	0.14B	0.13B	0.21B	0.07B	0.86B	0.84B	2.05B	-0.33B	-0.24B	0.73B	0.71B	0.89B	0.50B	0.47B	2.41B	0.01B	-0.12B	0.43B
Other Operating Expenses	0.08B	0.63B	0.20B	0.90B	0.31B	0.12B	0.15B	0.19B	0.39B	0.00B	0.01B	0.44B	0.37B	0.49B	0.47B	0.66B	-0.07B	-0.04B	-0.06B	2.00B	-0.07B	0.15B	-0.67B	-0.55B	13.21B	-0.39B	-0.31B	-0.82B	-0.66B	-2.27B	-0.63B	-1.10B	0.22B	-1.51B	-0.09B	-2.61B	-0.60B	-1.24B	-0.16B	-0.16B	-0.12B	-0.08B	-0.02B	1.10B	0.20B	2.00B	-0.23B	2.14B	0.29B	-0.11B	-0.32B	-0.49B	0.80B	-0.66B	-1.26B	0.89B	0.36B	0.35B	-0.46B	-0.71B	-0.68B	-0.40B	-0.44B	-1.96B	-0.01B	0.16B	0.03B
Operating Expenses	-4.78B	-5.06B	-4.97B	-6.67B	-5.48B	-8.06B	-4.72B	-8.78B	-4.80B	-5.32B	-4.83B	-14.94B	-5.00B	-5.01B	-5.27B	-15.95B	-4.86B	-5.28B	-4.67B	-10.75B	-4.81B	-4.99B	-4.90B	-7.77B	-3.38B	-4.64B	-3.79B	-13.41B	-3.65B	-1.82B	-3.17B	-4.91B	-4.11B	-3.08B	-4.34B	-14.65B	-4.47B	-4.61B	-4.58B	-4.76B	-4.53B	-4.76B	-5.05B	-16.26B	-5.26B	-4.98B	-4.92B	-15.34B	-3.45B	-3.85B	-4.13B	-4.60B	-3.84B	-3.30B	-3.17B	-14.20B	-4.47B	-4.75B	-4.17B	-18.66B	-3.57B	-4.47B	-6.36B	-19.94B	-4.44B	-5.67B	-4.87B
Operating Income	2.84B	3.69B	3.65B	4.37B	3.74B	0.96B	3.30B	-0.51B	3.26B	2.90B	3.41B	2.95B	3.20B	2.75B	2.65B	3.08B	2.46B	2.21B	2.43B	11.38B	1.76B	1.91B	1.18B	5.70B	13.98B	0.51B	1.59B	8.59B	1.04B	-0.22B	1.88B	1.37B	2.13B	-0.03B	2.46B	1.18B	1.72B	1.06B	2.49B	2.00B	1.86B	1.91B	2.65B	2.45B	2.58B	3.54B	2.40B	1.40B	1.67B	1.78B	1.90B	0.66B	3.08B	1.36B	1.40B	3.96B	2.53B	2.68B	2.47B	10.90B	1.89B	2.08B	0.25B	11.74B	2.79B	2.70B	3.50B
EBIT	2.84B	3.69B	3.65B	4.37B	3.74B	0.96B	3.30B	-0.51B	3.26B	2.90B	3.41B	2.95B	3.20B	2.75B	2.65B	3.08B	2.46B	2.21B	2.43B	11.38B	1.76B	1.91B	1.18B	5.70B	13.98B	0.51B	1.59B	8.59B	1.04B	-0.22B	1.88B	1.37B	2.13B	-0.03B	2.46B	1.18B	1.72B	1.06B	2.49B	2.00B	1.86B	1.91B	2.65B	2.45B	2.58B	3.54B	2.40B	1.40B	1.67B	1.78B	1.90B	0.66B	3.08B	1.36B	1.40B	3.96B	2.53B	2.68B	2.47B	10.90B	1.89B	2.08B	0.25B	11.74B	2.79B	2.70B	3.50B
Non-operating items
Interest & Investment Income	0.04B	0.03B	0.03B	0.01B	0.03B	0.03B	0.03B	0.09B	0.03B	0.04B	0.03B	0.05B	0.10B	0.01B	0.03B	0.04B	0.04B	0.02B	0.02B	0.10B	0.03B	0.03B	0.02B	0.03B	0.05B	0.02B	0.03B	0.06B	0.03B	0.03B	0.02B	0.02B	0.03B	0.02B	0.02B	-0.01B	0.03B	0.04B	0.01B	0.03B	0.04B	0.03B	0.04B	0.01B	0.05B	0.00B	-0.00B	0.06B	0.01B	0.01B	0.00B	0.00B	0.01B	0.03B	0.03B	0.03B	0.04B	0.04B	0.03B	0.08B	0.04B	0.03B	0.04B	0.07B	0.07B	0.07B	0.04B
Other Non Operating Income		-1.54B		2.19B	2.34B	-1.45B	4.55B	-0.97B	2.53B	1.96B	-1.99B	0.43B		4.83B	1.56B	-0.47B		2.66B	1.51B	4.51B	0.89B	1.27B	-1.04B	1.71B	11.15B		-1.14B	-21.75B				2.52B			1.79B					1.00B	0.92B	0.96B	1.38B	1.45B		3.32B	2.16B	1.63B		2.40B	1.58B	0.86B		1.74B	11.16B	17.35B	2.21B	1.80B	1.28B	0.89B	1.26B	1.58B	0.35B	0.34B	2.30B	2.47B	3.14B
Non Operating Income				0.02B				0.03B				0.01B				0.05B				-0.03B				0.01B				0.03B				0.03B
Net income details
EBT	2.77B	3.48B	3.39B	4.05B	3.49B	-0.88B	3.06B	-0.75B	3.95B	2.60B	3.13B	12.10B	2.95B	2.46B	2.38B	2.77B	2.19B	1.98B	2.17B	10.76B	1.49B	1.66B	0.92B	4.70B	15.05B	0.23B	1.34B	-0.63B	0.80B	-0.46B	1.67B	0.53B	1.92B	-0.23B	2.24B	1.17B	1.54B	0.84B	2.22B	1.77B	1.69B	1.63B	2.41B	2.20B	2.35B	3.28B	2.16B	1.08B	1.43B	1.50B	1.64B	0.41B	2.81B	1.13B	1.19B	3.51B	2.32B	2.49B	2.27B	4.83B	1.72B	1.89B	0.08B	3.66B	2.66B	2.52B	3.31B
Tax Provisions	-0.80B	-1.01B	-0.96B	-1.06B	-0.44B	-0.47B	-0.74B	-2.90B	-0.50B	-0.73B	-0.80B	-3.52B	-0.63B	-0.37B	-0.50B	-3.09B	-0.40B	-0.31B	-0.61B	-0.07B	-0.38B	-0.48B	-0.27B	-0.22B	-2.86B	-0.06B	-0.34B	-0.02B	-0.56B	-0.25B	-0.51B	-0.26B	-0.41B	0.12B	-0.41B	-1.80B	-0.28B	-0.19B	-0.25B	-0.10B	-0.25B	-0.28B	-0.29B	-1.23B	-0.33B	-0.25B	-0.31B	-0.77B	-0.21B	0.28B	-0.34B	0.16B	-0.20B	-0.19B	-0.27B	-0.83B	-0.28B	-0.30B	-0.33B	-0.94B	-0.21B	-0.24B	0.00B	-0.68B	-0.20B	-0.32B	-0.42B
Profit After Tax	3.58B	4.49B	4.35B	5.11B	3.93B	-0.42B	3.80B	2.15B	4.45B	3.32B	3.93B	15.62B	3.58B	2.83B	2.88B	5.86B	2.59B	2.29B	2.78B	10.83B	1.87B	2.14B	1.19B	4.92B	17.91B	0.29B	1.69B	-0.61B	1.36B	-0.21B	2.19B	0.78B	2.33B	-0.35B	2.65B	2.97B	1.82B	1.03B	2.47B	1.86B	1.94B	1.90B	2.70B	3.43B	2.69B	3.53B	2.47B	1.85B	1.64B	1.21B	1.98B	0.25B	3.01B	1.32B	1.47B	4.34B	2.60B	2.79B	2.59B	5.77B	1.93B	2.13B	0.08B	4.33B	2.85B	2.84B	3.73B
Equity Income	-0.02B	0.03B	0.04B	0.02B	0.04B	0.03B	0.02B	-0.13B	0.03B	0.00B	-0.00B	0.02B	-0.02B		-0.01B	0.05B	0.02B	0.01B	0.02B	0.07B	-0.00B	0.01B	0.02B	0.05B	-0.03B	-0.00B	-0.00B	-0.01B	0.50B	-0.00B	-0.00B	0.00B	-0.01B	-0.00B	0.01B	0.02B	0.01B	0.00B	0.02B	0.01B	0.07B	-0.01B	0.02B	0.10B	0.01B	0.02B	0.01B	0.04B	0.02B	0.02B	0.00B	-0.00B	0.00B	-0.00B	-0.00B	0.00B	-0.00B	-0.00B	0.01B	-0.01B	-0.00B	-0.00B	-0.00B	-0.00B		0.01B	0.01B
Net Income - Minority	-0.53B	-0.49B	-0.58B	-1.20B									0.02B	0.02B	0.02B	0.02B	0.91B	0.90B	0.91B	-0.95B	1.11B	1.13B	1.12B	1.08B					-0.01B							0.04B		12.67B	12.15B	11.99B			0.01B	0.01B
Income from Non-Controlling Interests	1.97B	2.47B	2.43B	3.00B	2.52B	-0.65B	2.31B	-1.00B	2.54B	1.87B	2.32B	0.44B	2.16B	2.09B	1.89B	0.14B	1.60B	1.66B	1.57B	4.06B	1.19B	1.18B	0.64B	1.62B	12.19B	0.18B	1.00B	-0.65B	0.50B	-0.71B	1.16B	0.82B	1.51B	-0.11B	1.83B	2.88B	1.06B	0.65B	1.97B	1.67B	1.28B	1.35B	2.12B	1.95B	2.15B	3.03B	1.85B	1.11B	1.74B	2.15B	1.89B	1.25B	2.91B	1.23B	12.80B	18.32B	1.98B	2.18B	1.94B	6.59B	1.37B	1.65B	0.08B	3.79B	2.23B	2.20B	2.89B
Income from Continuing Operations	3.58B	4.49B	4.35B	5.11B	3.93B	-0.42B	3.80B	2.15B	4.45B	3.32B	3.93B	15.62B	3.58B	2.83B	2.88B	5.86B	2.59B	2.29B	2.78B	10.83B	1.87B	2.14B	1.19B	4.92B	17.91B	0.29B	1.69B	-0.61B	1.36B	-0.21B	2.19B	0.78B	2.33B	-0.35B	2.65B	2.97B	1.82B	1.03B	2.47B	1.86B	1.94B	1.90B	2.70B	3.43B	2.69B	3.53B	2.47B	1.85B	1.64B	1.21B	1.98B	0.25B	3.01B	1.32B	1.47B	4.34B	2.60B	2.79B	2.59B	5.77B	1.93B	2.13B	0.08B	4.33B	2.85B	2.84B	3.73B
Consolidated Net Income	3.58B	4.49B	4.35B	5.11B	3.93B	-0.42B	3.80B	2.15B	4.45B	3.32B	3.93B	15.62B	3.58B	2.83B	2.88B	5.86B	2.59B	2.29B	2.78B	10.83B	1.87B	2.14B	1.19B	4.92B	17.91B	0.29B	1.69B	-0.61B	1.36B	-0.21B	2.19B	0.78B	2.33B	-0.35B	2.65B	2.97B	1.82B	1.03B	2.47B	1.86B	1.94B	1.90B	2.70B	3.43B	2.69B	3.53B	2.47B	1.85B	1.64B	1.21B	1.98B	0.25B	3.01B	1.32B	1.47B	4.34B	2.60B	2.79B	2.59B	5.77B	1.93B	2.13B	0.08B	4.33B	2.85B	2.84B	3.73B
Income towards Parent Company	1.92B	2.43B	2.37B	2.93B	2.43B	-0.65B	2.23B	-1.09B	2.44B	1.80B	2.22B	1.97B	2.08B	1.99B	1.77B	1.36B	1.49B	1.60B	1.50B	8.80B	1.11B	1.10B	0.67B	4.37B	12.27B	0.23B	0.83B	5.47B	0.40B	-0.62B	1.06B	0.32B	1.30B	-0.23B	1.59B	-0.72B	0.76B	0.60B	1.85B	1.56B	1.08B	1.24B	1.91B	1.67B	2.01B	2.81B	1.61B	0.89B	1.48B	1.95B	1.61B	1.01B	2.42B	1.06B	12.75B	3.10B	1.81B	2.03B	1.85B	3.86B	1.33B	1.48B	-0.08B	2.85B	2.05B	1.93B	2.72B
Net Income towards Common Stockholders	1.92B	2.43B	2.37B	2.93B	2.43B	-0.65B	2.23B	-1.09B	2.44B	1.80B	2.22B	1.97B	2.08B	1.99B	1.77B	1.36B	1.49B	1.60B	1.50B	8.80B	1.11B	1.10B	0.67B	4.37B	12.27B	0.23B	0.83B	5.47B	0.40B	-0.62B	1.06B	0.32B	1.30B	-0.23B	1.59B	-0.72B	0.76B	0.60B	1.85B	1.56B	1.08B	1.24B	1.91B	1.67B	2.01B	2.81B	1.61B	0.89B	1.48B	1.95B	1.61B	1.01B	2.42B	1.06B	12.75B	3.10B	1.81B	2.03B	1.85B	3.86B	1.33B	1.48B	-0.08B	2.85B	2.05B	1.93B	2.72B
Additional items
EPS (Basic)				0.71				-0.26	0.59	0.43	0.53	0.47	0.52	0.49	0.44	0.34	0.38	0.41	0.38	2.27	0.28	0.28	0.17	1.12	3.15	0.06	0.21	1.41	0.10	-0.16	0.27	0.08	0.33	-0.06	0.40	-0.18	0.19	0.15	0.47	0.39	0.27	0.31	0.48	0.42	0.50	0.70	0.40	0.22	0.37	0.49	0.40	0.25	0.60	0.26	3.16	0.77	0.44	0.50	0.46	0.95	0.33	0.37	-0.02	0.70	0.50	0.47	0.67
EPS (Weighted Average and Diluted)	0.00				0.00	0.00	0.00			0.00	0.00												0.00
Shares Outstanding (Weighted Average)				4.15B				4.15B	4.16B	4.16B	4.16B	4.16B	4.04B	4.04B	4.04B	4.04B	3.94B	3.94B	3.94B	3.88B	3.88B	3.88B	3.88B	3.88B	3.89B	3.89B	3.89B	3.89B	3.90B	3.90B	3.90B	3.90B	3.93B	3.93B	3.93B	3.93B	3.97B	3.97B	3.97B	3.97B	3.97B	3.97B	3.97B	3.97B	3.99B	3.99B	3.99B	3.99B	4.02B	4.00B	4.00B	4.01B	4.03B	3.99B	4.03B	4.03B	4.09B	4.05B	4.05B	4.05B	4.06B	4.04B	4.08B	4.05B	4.08B	4.09B	4.06B
Shares Outstanding (Diluted Average)	7,311,337.39B				7,997,404.35B	7,654,383.72B	7,950,952.75B			8,358,099.80B	8,246,841.46B												8,164,136.82B
EBITDA	2.84B	3.69B	3.65B	4.37B	3.74B	0.96B	3.30B	-0.51B	3.26B	2.90B	3.41B	2.95B	3.20B	2.75B	2.65B	3.08B	2.46B	2.21B	2.43B	11.38B	1.76B	1.91B	1.18B	5.70B	13.98B	0.51B	1.59B	0.06B	1.04B	-0.22B	1.88B	1.37B	2.13B	-0.03B	2.46B	1.18B	1.72B	1.06B	2.49B	2.00B	1.86B	1.91B	2.65B	2.45B	2.58B	3.54B	2.40B	1.40B	1.67B	1.78B	1.90B	0.66B	3.08B	1.36B	1.40B	3.96B	2.53B	2.68B	2.47B	10.90B	1.89B	2.08B	0.25B	11.74B	2.79B	2.70B	3.50B
Interest Expenses	-0.29B	-0.26B	-0.33B	-0.35B	-0.32B	-0.28B	-0.31B	1.13B	-0.31B	-0.34B	-0.31B	-0.32B	0.26B	-0.30B	-0.31B	-0.36B	-0.32B	-0.30B	-0.30B	-0.28B	0.27B	-0.30B	-0.30B	-1.15B	0.24B	-0.30B	-0.27B	-0.30B	-0.26B	-0.26B	-0.24B	-0.02B	0.21B	-0.25B	-0.25B	-0.20B	-0.23B	-0.26B	-0.30B	-0.27B	-0.29B	-0.30B	-0.30B	-1.17B	0.24B	-0.28B	-0.25B	-1.18B	-0.27B	-0.26B	-0.27B	-0.25B	0.27B	-0.26B	-0.24B	-1.03B	0.21B	-0.23B	-0.23B	-0.98B	-0.21B	-0.22B	-0.20B	-0.86B	0.14B	-0.25B	-0.23B
Tax Rate						52.79%																						2.88%		54.72%																				18.79%		38.61%											1.56%

Research Tools

GSK Income Statement (2009-2025) | GSK

Create an account

Sign In

Reset Password

Get Pro for 60% off